In vitro two-way drug–drug interaction study shows no antagonism or potentiation between post-phase III anti-HSV pritelivir and nine licensed anti-HIV drugs (INSTI, NNRTI, NRTI, and CAI) (ESCMID Global 2026) - Feb 4, 2026 - Pres time: Apr 18, 2026; 12:00 PM - 01:30 PM; Location: Poster area; No abstract available
P3 data • Preclinical • Human Immunodeficiency Virus • Infectious Disease
|